Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
187 | 3 | NEUROTROPHINS//BDNF//BRAIN DERIVED NEUROTROPHIC FACTOR | 55761 |
873 | 2 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 11647 |
9610 | 1 | NERVE GROWTH FACTOR//TANEZUMAB//NGF | 1169 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NERVE GROWTH FACTOR | authKW | 812000 | 27% | 9% | 318 |
2 | TANEZUMAB | authKW | 633962 | 2% | 87% | 27 |
3 | NGF | authKW | 316384 | 12% | 8% | 143 |
4 | NEUROTROPHINS | authKW | 278649 | 16% | 6% | 183 |
5 | NEUROBIOL MOL MED | address | 222806 | 5% | 14% | 59 |
6 | TRKA | authKW | 150293 | 5% | 10% | 58 |
7 | NGF SECT | address | 149763 | 1% | 56% | 10 |
8 | FULRANUMAB | authKW | 112327 | 0% | 83% | 5 |
9 | TRKANGFR | authKW | 86267 | 0% | 80% | 4 |
10 | FASINUMAB | authKW | 80877 | 0% | 100% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Neurosciences | 2595 | 29% | 0% | 335 |
2 | Allergy | 2046 | 6% | 0% | 74 |
3 | Immunology | 1337 | 17% | 0% | 204 |
4 | Rheumatology | 834 | 5% | 0% | 60 |
5 | Respiratory System | 503 | 6% | 0% | 70 |
6 | Anesthesiology | 380 | 4% | 0% | 44 |
7 | Cell Biology | 362 | 11% | 0% | 127 |
8 | Ophthalmology | 196 | 4% | 0% | 48 |
9 | Clinical Neurology | 146 | 6% | 0% | 75 |
10 | Physiology | 138 | 5% | 0% | 55 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NEUROBIOL MOL MED | 222806 | 5% | 14% | 59 |
2 | NGF SECT | 149763 | 1% | 56% | 10 |
3 | PHYSIOL VESALGASSE 1 | 80877 | 0% | 100% | 3 |
4 | CLIN CHEM MOL DIAGNOST | 67179 | 2% | 10% | 24 |
5 | CELLULAR TISSUE ENGN | 61265 | 0% | 45% | 5 |
6 | P MED MED SOLNA | 53918 | 0% | 100% | 2 |
7 | ALLERGY ASTHMA CLIN | 42188 | 1% | 26% | 6 |
8 | ANALYT PROC TECHNOL | 35944 | 0% | 67% | 2 |
9 | CIR OPHTHALMOL | 35944 | 0% | 67% | 2 |
10 | MED INFECT P DIS | 35944 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ARCHIVES ITALIENNES DE BIOLOGIE | 12603 | 2% | 2% | 20 |
2 | JOURNAL OF NEUROIMMUNOLOGY | 3043 | 2% | 0% | 28 |
3 | CLINICAL AND EXPERIMENTAL ALLERGY | 2982 | 2% | 0% | 24 |
4 | PAIN | 2068 | 2% | 0% | 25 |
5 | GROWTH FACTORS | 1623 | 1% | 1% | 7 |
6 | INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1212 | 1% | 0% | 14 |
7 | NEUROSCIENCE LETTERS | 938 | 3% | 0% | 34 |
8 | AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 862 | 1% | 0% | 13 |
9 | CYTOKINE & GROWTH FACTOR REVIEWS | 792 | 0% | 1% | 5 |
10 | OSTEOARTHRITIS AND CARTILAGE | 775 | 1% | 0% | 10 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NERVE GROWTH FACTOR | 812000 | 27% | 9% | 318 | Search NERVE+GROWTH+FACTOR | Search NERVE+GROWTH+FACTOR |
2 | TANEZUMAB | 633962 | 2% | 87% | 27 | Search TANEZUMAB | Search TANEZUMAB |
3 | NGF | 316384 | 12% | 8% | 143 | Search NGF | Search NGF |
4 | NEUROTROPHINS | 278649 | 16% | 6% | 183 | Search NEUROTROPHINS | Search NEUROTROPHINS |
5 | TRKA | 150293 | 5% | 10% | 58 | Search TRKA | Search TRKA |
6 | FULRANUMAB | 112327 | 0% | 83% | 5 | Search FULRANUMAB | Search FULRANUMAB |
7 | TRKANGFR | 86267 | 0% | 80% | 4 | Search TRKANGFR | Search TRKANGFR |
8 | FASINUMAB | 80877 | 0% | 100% | 3 | Search FASINUMAB | Search FASINUMAB |
9 | TROPOMYOSIN RELATED KINASE | 74649 | 1% | 46% | 6 | Search TROPOMYOSIN+RELATED+KINASE | Search TROPOMYOSIN+RELATED+KINASE |
10 | ANTI NGF | 73380 | 1% | 39% | 7 | Search ANTI+NGF | Search ANTI+NGF |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |